Sarcoidosis and uveitis

Autoimmunity Reviews

Volumn 13, Issue 8, 2014, Pages 840-849

  Jamilloux, Yvan ^a   Kodjikian, Laurent ^a   Broussolle, Christiane ^a   Sève, Pascal ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Anti TNF ; FDG PET; Ocular sarcoidosis; Sarcoidosis; Uveitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; COMPLEMENT FACTOR H; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; FLUORODEOXYGLUCOSE F 18; HEAT SHOCK PROTEIN 70; HLA ANTIGEN CLASS 2; INFLIXIMAB; INTERLEUKIN 10; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

BEHCET DISEASE; BTNL2 GENE; CD4 CD8 RATIO; CHORIORETINOPATHY; CHOROIDITIS; CHROMOSOME 5Q; COMPLEMENT FACTOR H GENE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; EYE BIOPSY; EYE DISEASE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HEAT SHOCK PROTEIN 70 GENE; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HISTOPLASMOSIS; HLA ANTIGEN CLASS 2 GENE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERLEUKIN 10 GENE; INTERMEDIATE UVEITIS; INTESTINE LIPODYSTROPHY; INTRAOCULAR LYMPHOMA; IRIDOCYCLITIS; LABORATORY TEST; LEPTOSPIROSIS; LYME DISEASE; MINOR SALIVA GLAND; MULTICENTER STUDY (TOPIC); MULTIPLE SCLEROSIS; OCULAR SARCOIDOSIS; OPHTHALMOLOGY; PIGMENT DISORDER; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; REVIEW; SALIVARY GLAND BIOPSY; SARCOIDOSIS; SYMPATHETIC OPHTHALMIA; SYPHILIS; SYSTEMATIC REVIEW (TOPIC); THORAX RADIOGRAPHY; TOXOPLASMOSIS; TREATMENT RESPONSE; TUBERCULIN TEST; TUBERCULOSIS; UVEITIS; VITRECTOMY; VOGT KOYANAGI SYNDROME;

ANTI-TNFΑ; FDG-PET; OCULAR SARCOIDOSIS; SARCOIDOSIS; UVEITIS;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS; SARCOIDOSIS; UVEITIS;

EID: 84902215195     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.04.001     Document Type: Review

References (109)

1. Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N Engl J Med 2007, 357:2153-2165.
2. Hillerdal G., Nöu E., Osterman K., Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984, 130:29-32.
3. Rybicki B.A., Major M., Popovich J., Maliarik M.J., Iannuzzi M.C. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997, 145:234-241.
4. Baughman R.P., Teirstein A.S., Judson M.A., Rossman M.D., Yeager H., Bresnitz E.A., et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001, 164(10 Pt 1):1885-1889.
5. Neville E., Walker A.N., James D.G. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. QJM 1983, 52:525-533.
6. Siltzbach L.E., James D.G., Neville E., Turiaf J., Battesti J.P., Sharma O.P., et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974, 57:847-852.
7. Mayock R.L., Bertrand P., Morrison C.E., Scott J.H. Manifestations of sarcoidosis. Analysis of 145 patients, with a review of nine series selected from the literature. Am J Med 1963, 35:67-89.
8. Jamilloux Y., Bonnefoy M., Valeyre D., Varron L., Broussolle C., Sève P. Elderly-onset sarcoidosis: prevalence, clinical course, and treatment. Drugs Aging 2013, 30:969-978.
9. Dempsey O.J., Paterson E.W., Kerr K.M., Denison A.R. Sarcoidosis. BMJ 2009, 339:b3206.
10. Iannuzzi M.C., Fontana J.R. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA 2011, 305:391-399.
11. Bodaghi B., Touitou V., Fardeau C., Chapelon C., LeHoang P. Ocular sarcoidosis. Presse Med 2012, 41(6 Pt 2):e349-e354.
12. Drent M., Costabel U. European respiratory monograph 32: sarcoidosis 2005, European Respiratory Society.
13. Birnbaum A.D., Oh F.S., Chakrabarti A., Tessler H.H., Goldstein D.A. Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis. Arch Ophthalmol 2011, 129:409-413.
14. Evans M., Sharma O., LaBree L., Smith R.E., Rao N.A. Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. Ophthalmology 2007, 114:325-333.
15. Grégoire M.-A., Kodjikian L., Varron L., Grange J.-D., Broussolle C., Seve P. Characteristics of uveitis presenting for the first time in the elderly: analysis of 91 patients in a tertiary center. Ocul Immunol Inflamm 2011, 19:219-226.
16. Varron L., Abad S., Kodjikian L., Sève P. Sarcoid uveitis: diagnostic and therapeutic update. Rev Med Interne 2011, 32:86-92.
17. Kitamei H., Kitaichi N., Namba K., Kotake S., Goda C., Kitamura M., et al. Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol 2009, 87:424-428.
18. Barisani-Asenbauer T., Maca S.M., Mejdoubi L., Emminger W., Machold K., Auer H. Uveitis-a rare disease often associated with systemic diseases and infections-a systematic review of 2619 patients. Orphanet J Rare Dis 2012, 7:57.
19. Bodaghi B., Cassoux N., Wechsler B., Hannouche D., Fardeau C., Papo T., et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore) 2001, 80:263-270.
20. Bouillet L., Sarrot-Reynauld F., Gonzalvez B., Massot C., Romanet J., Mouillon M. Diagnostic strategy in uveitis: a prospective study in 125 cases. J Fr Ophtalmol 2000, 23:569-575.
21. Jakob E., Reuland M.S., Mackensen F., Harsch N., Fleckenstein M., Lorenz H.-M., et al. Uveitis subtypes in a German interdisciplinary uveitis center-analysis of 1916 patients. J Rheumatol 2009, 36:127-136.
22. Oruc S., Kaplan A.D., Galen M., Kaplan H.J. Uveitis referral pattern in a Midwest University Eye Center. Ocul Immunol Inflamm 2003, 11:287-298.
23. Abad S., Meyssonier V., Allali J., Gouya H., Giraudet A.L., Monnet D., et al. Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patients. Arthritis Rheum 2004, 51:974-982.
24. Chung Y.-M., Lin Y.-C., Liu Y.-T., Chang S.-C., Liu H.-N., Hsu W.-H. Uveitis with biopsy-proven sarcoidosis in Chinese-a study of 60 patients in a uveitis clinic over a period of 20years. J Chin Med Assoc 2007, 70:492-496.
25. Khanna A., Sidhu U., Bajwa G., Malhotra V. Pattern of ocular manifestations in patients with sarcoidosis in developing countries. Acta Ophthalmol Scand 2007, 85:609-612.
26. Lee S.Y., Lee H.G., Kim D.S., Kim J.-G., Chung H., Yoon Y.H. Ocular sarcoidosis in a Korean population. J Korean Med Sci 2009, 24:413-419.
27. Rothova A., Alberts C., Glasius E., Kijlstra A., Buitenhuis H.J., Breebaart A.C. Risk factors for ocular sarcoidosis. Doc Ophthalmol Adv Ophthalmol 1989, 72:287-296.
28. Ganesh S.K., Agarwal M. Clinical and investigative profile of biopsy-proven sarcoid uveitis in India. Ocul Immunol Inflamm 2008, 16:17-22.
29. Judson M.A., Hirst K., Iyengar S.K., Rybicki B.A., El-Ghormli L., Baughman R.P., et al. Comparison of sarcoidosis phenotypes among affected African-American siblings. Chest 2006, 130:855-862.
30. Steele M.P., Brown K.K. Genetic predisposition to respiratory diseases: infiltrative lung diseases. Respiration 2007, 74:601-608.
31. Rybicki B.A., Iannuzzi M.C., Frederick M.M., Thompson B.W., Rossman M.D., Bresnitz E.A., et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001, 164:2085-2091.
32. Darlington P., Tallstedt L., Padyukov L., Kockum I., Cederlund K., Eklund A., et al. HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis. Eur Respir J 2011, 38:1151-1157.
33. Rossman M.D., Thompson B., Frederick M., Maliarik M., Iannuzzi M.C., Rybicki B.A., et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003, 73:720-735.
34. Sato H., Woodhead F.A., Ahmad T., Grutters J.C., Spagnolo P., van den Bosch J.M.M., et al. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet 2010, 19:4100-4111.
35. Suzuki H., Ota M., Meguro A., Katsuyama Y., Kawagoe T., Ishihara M., et al. Genetic characterization and susceptibility for sarcoidosis in Japanese patients: risk factors of BTNL2 gene polymorphisms and HLA class II alleles. Invest Ophthalmol Vis Sci 2012, 53:7109-7115.
36. Kuroda H., Saijo Y., Fujiuchi S., Takeda H., Ohsaki Y., Hasebe N. Relationship between cytokine single nucleotide polymorphisms and sarcoidosis among Japanese subjects. Sarcoidosis Vasc Diffuse Lung Dis 2013, 30:36-42.
37. Sakuyama K., Meguro A., Ota M., Ishihara M., Uemoto R., Ito H., et al. Lack of association between IL10 polymorphisms and sarcoidosis in Japanese patients. Mol Vis 2012, 18:512-518.
38. Kim H.S., Choi D., Lim L.L., Allada G., Smith J.R., Austin C.R., et al. Association of interleukin 23 receptor gene with sarcoidosis. Dis Markers 2011, 31:17-24.
39. Akahoshi M., Ishihara M., Namba K., Kitaichi N., Ando Y., Takenaka S., et al. Mutation screening of the CARD15 gene in sarcoidosis. Tissue Antigens 2008, 71:564-567.
40. Asukata Y., Ota M., Meguro A., Katsuyama Y., Ishihara M., Namba K., et al. Lack of association between toll-like receptor 4 gene polymorphisms and sarcoidosis-related uveitis in Japan. Mol Vis 2009, 15:2673-2682.
41. Martin T.M., Doyle T.M., Smith J.R., Dinulescu D., Rust K., Rosenbaum J.T. Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15). Am J Ophthalmol 2003, 136:933-935.
42. Spagnolo P., Sato H., Marshall S.E., Antoniou K.M., Ahmad T., Wells A.U., et al. Association between heat shock protein 70/Hom genetic polymorphisms and uveitis in patients with sarcoidosis. Invest Ophthalmol Vis Sci 2007, 48:3019-3025.
43. Thompson I.A., Liu B., Sen H.N., Jiao X., Katamay R., Li Z., et al. Association of complement factor H tyrosine 402 histidine genotype with posterior involvement in sarcoid-related uveitis. Am J Ophthalmol 2013, 155. [1068-1074.e1].
44. Jones N.P. Sarcoidosis and uveitis. Ophthalmol Clin North Am 2002, 15:319-326. [vi].
45. Papadia M., Herbort C.P., Mochizuki M. Diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm 2010, 18:432-441.
46. Koop A., Ossewaarde A., Rothova A. Peripheral multifocal chorioretinitis: complications, prognosis and relation with sarcoidosis. Acta Ophthalmol 2013, 91:492-497.
47. Herbort C.P., Rao N.A., Mochizuki M., members of Scientific Committee of First International Workshop on Ocular Sarcoidosis International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 2009, 17:160-169.
48. Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol 2000, 84:110-116.
49. CRICK R.P. Ocular sarcoidosis. Trans Ophthalmol Soc U K 1955, 75:189-206.
50. Uyama M. Uveitis in sarcoidosis. Int Ophthalmol Clin 2002, 42:143-150.
51. Ohguro N., Sonoda K.-H., Takeuchi M., Matsumura M., Mochizuki M. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol 2012, 56:432-435.
52. Ang M., Wong W.L., Li X., Chee S.-P. Interferon γ release assay for the diagnosis of uveitis associated with tuberculosis: a Bayesian evaluation in the absence of a gold standard. Br J Ophthalmol 2013, 97:1062-1067.
53. Gineys R., Bodaghi B., Carcelain G., Cassoux N., Boutin L.T.H., Amoura Z., et al. QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation. Am J Ophthalmol 2011, 152. [433-440.e1].
54. Sakata V.M., da Silva F.T., Hirata C.E., de Carvalho J.F., Yamamoto J.H. Diagnosis and classification of Vogt-Koyanagi-Harada disease. Autoimmun Rev 2014, 13:550-555.
55. Sfriso P., Caso F., Tognon S., Galozzi P., Gava A., Punzi L. Blau syndrome, clinical and genetic aspects. Autoimmun Rev 2012, 12:44-51.
56. Dana M.R., Merayo-Lloves J., Schaumberg D.A., Foster C.S. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 1846-1853, 1996:103.
57. Edelsten C., Pearson A., Joynes E., Stanford M.R., Graham E.M. The ocular and systemic prognosis of patients presenting with sarcoid uveitis. Eye 1999, 13(Pt 6):748-753.
58. Lardenoye C.W., Van der Lelij A., de Loos W.S., Treffers W.F., Rothova A. Peripheral multifocal chorioretinitis: a distinct clinical entity?. Ophthalmology 1820-1826, 1997:104.
59. Heinle R., Chang C. Diagnostic criteria for sarcoidosis. Autoimmun Rev 2014, 13:383-387.
60. Agarwal R., Srinivasan A., Aggarwal A.N., Gupta D. Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: a systematic review and meta-analysis. Respir Med 2012, 106:883-892.
61. Clement D.S., Postma G., Rothova A., Grutters J.C., Prokop M., de Jong P.A. Intraocular sarcoidosis: association of clinical characteristics of uveitis with positive chest high-resolution computed tomography findings. Br J Ophthalmol 2010, 94:219-222.
62. Foster C.S., Vitale A.T. Diagnosis and treatment of uveitis 2013, JP Medical Ltd.
63. Baarsma G.S., La Hey E., Glasius E., de Vries J., Kijlstra A. The predictive value of serum angiotensin converting enzyme and lysozyme levels in the diagnosis of ocular sarcoidosis. Am J Ophthalmol 1987, 104:211-217.
64. Caspers L.E., Ebraert H., Makhoul D., Willermain F., Michel O. Broncho-alveolar lavage (BAL) for the diagnosis of sarcoidosic uveitis. Ocul Immunol Inflamm 2014, 22:102-109.
65. Takahashi T., Azuma A., Abe S., Kawanami O., Ohara K., Kudoh S. Significance of lymphocytosis in bronchoalveolar lavage in suspected ocular sarcoidosis. Eur Respir J 2001, 18:515-521.
66. Khan F., Wessely Z., Chazin S.R., Seriff N.S. Conjunctival biopsy in sarcoidosis: a simple, safe, and specific diagnostic procedure. Ann Ophthalmol 1977, 9:671-676.
67. Spaide R.F., Ward D.L. Conjunctival biopsy in the diagnosis of sarcoidosis. Br J Ophthalmol 1990, 74:469-471.
68. Crick R., Hoyle C., Mather G. Conjunctival biopsy in sarcoidosis. Br Med J 1955, 2:1180-1181.
69. James D.G. The diagnosis and treatment of ocular sarcoidosis. Acta Med Scand Suppl 1964, 425:203-208.
70. Giotaki H., Constantopoulos S.H., Papadimitriou C.S., Moutsopoulos H.M. Labial minor salivary gland biopsy: a highly discriminatory diagnostic method between sarcoidosis and Sjögren's syndrome. Respiration 1986, 50:102-107.
71. Harvey J., Catoggio L., Gallagher P.J., Maddison P.J. Salivary gland biopsy in sarcoidosis. Sarcoidosis 1989, 6:47-50.
72. Mert A., Ozaras R., Tabak F., Pekmezci S., Demirkesen C., Ozturk R. Erythema nodosum: an experience of 10years. Scand J Infect Dis 2004, 36:424-427.
73. Nessan V.J., Jacoway J.R. Biopsy of minor salivary glands in the diagnosis of sarcoidosis. N Engl J Med 1979, 301:922-924.
74. Bernard C., Kodjikian L., Bancel B., Isaac S., Broussolle C., Seve P. Ocular sarcoidosis: when should labial salivary gland biopsy be performed?. Graefes Arch Clin Exp Ophthalmol 2013, 251:855-860.
75. Takase H., Shimizu K., Yamada Y., Hanada A., Takahashi H., Mochizuki M. Validation of international criteria for the diagnosis of ocular sarcoidosis proposed by the first international workshop on ocular sarcoidosis. Jpn J Ophthalmol 2010, 54:529-536.
76. Oahalou A., Schellekens P.A., de Groot-Mijnes J.D., Rothova A. Diagnostic pars plana vitrectomy and aqueous analyses in patients with uveitis of unknown cause. Retina 2014, 34:108-114.
77. Drancourt M., Berger P., Terrada C., Bodaghi B., Conrath J., Raoult D., et al. High prevalence of fastidious bacteria in 1520 cases of uveitis of unknown etiology. Medicine (Baltimore) 2008, 87:167-176.
78. Scott A.W., Mruthyunjaya P., McCallum R.M., Jaffe G.J. Diagnostic yield of vitreous biopsy in presumed sarcoidosis-related posterior segment inflammation. Graefes Arch Clin Exp Ophthalmol 2012, 250:1379-1385.
79. Kojima K., Maruyama K., Inaba T., Nagata K., Yasuhara T., Yoneda K., et al. The CD4/CD8 ratio in vitreous fluid is of high diagnostic value in sarcoidosis. Ophthalmology 2012, 119:2386-2392.
80. Keijsers R.G.M., van den Heuvel D.A.F., Grutters J.C. Imaging the inflammatory activity of sarcoidosis. Eur Respir J 2013, 41:743-751.
81. Sobic-Saranovic D., Grozdic I., Videnovic-Ivanov J., Vucinic-Mihailovic V., Artiko V., Saranovic D., et al. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis. J Nucl Med 2012, 53:1543-1549.
82. Rahmi A., Deshayes E., Maucort-Boulch D., Varron L., Grange J.D., Kodjikian L., et al. Intraocular sarcoidosis: association of clinical characteristics of uveitis with findings from 18F-labelled fluorodeoxyglucose positron emission tomography. Br J Ophthalmol 2012, 96:99-103.
83. Murray P.I., Bodaghi B., Sharma O.P. Systemic treatment of sarcoidosis. Ocul Immunol Inflamm 2011, 19:145-150.
84. Bae J.H., Lee C.S., Lee S.C. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-Tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Retina 2011, 31:111-118.
85. Weijtens O., Feron E.J., Schoemaker R.C., Cohen A.F., Lentjes E.G., Romijn F.P., et al. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol 1999, 128:192-197.
86. Pearson P.A., Comstock T.L., Ip M., Callanan D., Morse L.S., Ashton P., et al. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. Ophthalmology 2011, 118:1580-1587.
87. Lowder C., Belfort R., Lightman S., Foster C.S., Robinson M.R., Schiffman R.M., et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 2011, 129:545-553.
88. Costabel U., Hunninghake G.W. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999, 14:735-737.
89. Bonfioli A.A., Orefice F. Sarcoidosis. Semin Ophthalmol 2005, 20:177-182.
90. Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen J.H., Altaweel M.M., Holbrook J.T., Jabs D.A., Louis T.A., et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology 2011, 118:1916-1926.
91. Baughman R.P., Lower E.E., Ingledue R., Kaufman A.H. Management of ocular sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2012, 29:26-33.
92. Baughman R.P., Lower E.E. Leflunomide for chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004, 21:43-48.
93. Bhat P., Cervantes-Castañeda R.A., Doctor P.P., Anzaar F., Foster C.S. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm 2009, 17:185-190.
94. Wallis R.S. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis 2008, 8:601-611.
95. Maneiro J.R., Salgado E., Gomez-Reino J.J., Carmona L., BIOBADASER Study Group Efficacy and safety of TNF antagonists in sarcoidosis: data from the Spanish registry of biologics BIOBADASER and a systematic review. Semin Arthritis Rheum 2012, 42:89-103.
96. Baughman R.P., Drent M., Kavuru M., Judson M.A., Costabel U., du Bois R., et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006, 174:795-802.
97. Rossman M.D., Newman L.S., Baughman R.P., Teirstein A., Weinberger S.E., Miller W., et al. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006, 23:201-208.
98. Baughman R.P., Nunes H., Sweiss N.J., Lower E.E. Established and experimental medical therapy of pulmonary sarcoidosis. Eur Respir J 2013, 41:1424-1438.
99. Kamphuis L.S., Lam-Tse W.-K., Dik W.A., van Daele P.L., van Biezen P., Kwekkeboom D.J., et al. Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis. Am J Respir Crit Care Med 2011, 184:1214-1216.
100. Pariser R.J., Paul J., Hirano S., Torosky C., Smith M. A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis. J Am Acad Dermatol 2013, 68:765-773.
101. Comarmond C., Wechsler B., Bodaghi B., Cacoub P., Saadoun D. Biotherapies in Behçet's disease. Autoimmun Rev 2014, 13:762-769.
102. Saadoun D., Bodaghi B., Bienvenu B., Wechsler B., Sene D., Trad S., et al. Biotherapies in inflammatory ocular disorders: interferons, immunoglobulins, monoclonal antibodies. Autoimmun Rev 2013, 12:774-783.
103. Baughman R.P., Lower E.E., Bradley D.A., Raymond L.A., Kaufman A. Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Chest 2005, 128:1062-1067.
104. Erckens R.J., Mostard R.L.M., Wijnen P.A.H.M., Schouten J.S., Drent M. Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol 2012, 250:713-720.
105. Daïen C.I., Monnier A., Claudepierre P., Constantin A., Eschard J.-P., Houvenagel E., et al. Club Rhumatismes et Inflammation (CRI): sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford) 2009, 48:883-886.
106. Seve P., Varron L., Broussolle C., Denis P., Kodjikian L. Sarcoid-related uveitis occurring during adalimumab therapy. Ocul Immunol Inflamm 2012, 20:59-60.
107. Braswell R.A., Kline L.B. Neuro-ophthalmologic manifestations of sarcoidosis. Int Ophthalmol Clin 2007, 47:67-77. [ix].
108. Koczman J.J., Rouleau J., Gaunt M., Kardon R.H., Wall M., Lee A.G. Neuro-ophthalmic sarcoidosis: the University of Iowa experience. Semin Ophthalmol 2008, 23:157-168.
109. Prabhakaran V.C., Saeed P., Esmaeli B., Sullivan T.J., McNab A., Davis G., et al. Orbital and adnexal sarcoidosis. Arch Ophthalmol 2007, 125:1657-1662.